A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)

Clinical trial NCT05809752 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05809752
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leptomeningeal Disease Triple Negative Breast Cancer HER2-positive Breast Cancer

Start date: 2023-08-22
Primary completion: 2026-08-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.